Existing literature lacks information on the relationship between exposure to ambient air contaminants and Alzheimer's disease (AD) risk represented by simultaneous assessment of absolute and relative concentration-response patterns.
Objective
This study quantifies fine particulate matter (PM2.5)-exposure and AD-risk relationships with detailed analyses of the role of methodologic limitations and sources of bias (e.g., population heterogeneity) and identifies notable subpopulation differences and subpopulations most vulnerable to PM2.5 exposure.
Methods
Using Medicare and SEDAC data, we evaluated effects of PM2.5 exposure on AD risk using absolute and relative concentration-response functions through, respectively, age-adjusted rates and Cox-model estimates by sex/race/ethnicity/exposure groups.
Results
Analyses demonstrated that chronic PM2.5 exposure was significantly associated with increased AD risk, with substantial variation observed across sex and race/ethnicity-specific subgroups. Females showed higher absolute incidence, while males exhibited steeper relative risk increases with rising PM2.5 concentrations. Native Americans, residing primarily in low-exposure areas, demonstrated the steepest rise in hazard with increasing PM2.5 concentrations; Black and Asian subpopulations exhibited the lowest relative ratios. Nonlinearities were detected in exposure-response relationships. AD risk in Hispanics displayed notable geographic heterogeneity.
Conclusions
This study provides a background for evaluating health impacts of recent air-quality standards across the U.S. and their specific effects on AD risk in vulnerable subpopulation groups. Future research should employ more-flexible modeling techniques (e.g., spline-based or piecewise methods), integrate mechanistic studies, and utilize data on social determinants to further elucidate the biological and structural pathways linking PM2.5 to AD diagnosis, explain observed disparities through associated risk factors, and identify causal factors mediating the relationship.
ShiLWuXYazdiMD, et al.Long-term effects of PM2· 5 on neurological disorders in the American Medicare population: a longitudinal cohort study. Lancet Planetary Health2020; 4: e557–e565.
2.
Yitshak-SadeMNetheryRSchwartzJD, et al.PM2. 5 and hospital admissions among Medicare enrollees with chronic debilitating brain disorders. Sci Total Environ2021; 755: 142524.
3.
KioumourtzoglouMASchwartzJDWeisskopfMG, et al.Long-term PM2. 5 exposure and neurological hospital admissions in the northeastern United States. Environ Health Perspect2016; 124: 23–29.
4.
DimakakouEJohnstonHJStreftarisG, et al.Exposure to environmental and occupational particulate air pollution as a potential contributor to neurodegeneration and diabetes: a systematic review of epidemiological research. Int J Environ Res Public Health2018; 15: 1704.
5.
RhewSHKravchenkoJLyerlyHK. Exposure to low-dose ambient fine particulate matter PM2. 5 and Alzheimer’s disease, non-Alzheimer’s dementia, and Parkinson’s disease in North Carolina. PloS One2021; 16: e0253253.
6.
GongYZhangXZhaoX, et al.Global ambient particulate matter pollution and neurodegenerative disorders: a systematic review of literature and meta-analysis. Environ Sci Pollut Res2023; 30: 39418–39430.
7.
ChengSJinYDouY, et al.Long-term particulate matter 2.5 exposure and dementia: a systematic review and meta-analysis. Public Health2022; 212: 33–41.
8.
ShiLSteenlandKLiH, et al.A national cohort study (2000–2018) of long-term air pollution exposure and incident dementia in older adults in the United States. Nat Commun2021; 12: 6754.
9.
YounanDWangXGruenewaldT, et al.Racial/ethnic disparities in Alzheimer’s disease risk: role of exposure to ambient fine particles. J Gerontol A Biol Sci Med Sci2022; 77: 977–985.
10.
López-GraneroCPolyanskayaLRuiz-SobremazasD, et al.Particulate matter in human elderly: higher susceptibility to cognitive decline and age-related diseases. Biomolecules2023; 14: 35.
11.
RuMBrauerMLamarqueJF, et al.Exploration of the global burden of dementia attributable to PM2. 5: what do we know based on current evidence?Geohealth2021; 5: e2020GH000356.
12.
GuzmánPTarín-CarrascoPMorales-Suárez-VarelaM, et al.Effects of air pollution on dementia over Europe for present and future climate change scenarios. Environ Res2022; 204: 112012.
13.
GeRWangYZhangZ, et al.Association of long-term exposure to various ambient air pollutants, lifestyle, and genetic predisposition with incident cognitive impairment and dementia. BMC Public Health2024; 24: 179.
14.
U.S. Environmental Protection Agency. Reconsideration of the national ambient air quality standards for particulate matter. Washington, DC: U.S. Environmental Protection Agency, 2024.
15.
World Health Organization. WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. 1st ed. Geneva: World Health Organization, 2021.
16.
GoshuaAAkdisCANadeauKC. World Health Organization global air quality guideline recommendations: executive summary. Allergy2022; 77: 1955–1960.
17.
ShiLZhuQWangY, et al.Incident dementia and long-term exposure to constituents of fine particle air pollution: a national cohort study in the United States. Proc Natl Acad Sci U S A2023; 120: e2211282119.
18.
ChenHKwongJCCopesR, et al.Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study. Lancet2017; 389: 718–726.
19.
IlangoSDChenHHystadP, et al.The role of cardiovascular disease in the relationship between air pollution and incident dementia: a population-based cohort study. Int J Epidemiol2020; 49: 36–44.
20.
QinMMKhoshnevisNDominiciF, et al.Comparing traditional and causal inference methodologies for evaluating impacts of long-term air pollution exposure on hospitalization with Alzheimer disease and related dementias. Am J Epidemiol2025; 194: 64–72.
21.
AkushevichIKravchenkoJUkraintsevaS, et al.Age patterns of incidence of geriatric disease in the US elderly population: medicare-based analysis. J Am Geriatr Soc2012; 60: 323–327.
22.
DiQAminiHShiL, et al.An ensemble-based model of PM2. 5 concentration across the contiguous United States with high spatiotemporal resolution. Environ Int2019; 130: 104909.
23.
DiQWeiYShteinA, et al.Daily and annual PM2. 5 concentrations for the contiguous United States, 1-km grids, v1 (2000–2016). Palisades, NY: NASA Socioeconomic Data and Applications Center (SEDAC), 2021.
24.
RequiaWJDiQSilvernR, et al.An ensemble learning approach for estimating high spatiotemporal resolution of ground-level ozone in the contiguous U.S. Environ Sci Technol2020; 54: 11037–11047.
25.
DiQAminiHShiL, et al.Assessing NO2 concentration and model uncertainty with high spatiotemporal resolution across the contiguous United States. Environ Sci Technol2020; 54: 1372–1384.
26.
KeyfitzN. Sampling variance of standardized mortality rates. Human Biol1966; 38: 309–317.
27.
JarrínOFNyandegeANGrafovaIB, et al.Validity of race and ethnicity codes in Medicare administrative data compared with gold-standard self-reported race collected during routine home health care visits. Med Care2020; 58: e1–e8.
28.
LeeKKMillerMRShahAS. Air pollution and stroke. J Stroke2018; 20: 2–11.
29.
DanielsMJDominiciFSametJM, et al.Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. Am J Epidemiol2000; 152: 397–406.
30.
Calderón-GarcidueñasLSoltACHenríquez-RoldánC, et al.Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid β-42 and α-synuclein in children and young adults. Toxicol Pathol2008; 36: 289–310.
31.
NunezYBoehmeAKWeisskopfMG, et al.Fine particle exposure and clinical aggravation in neurodegenerative diseases in New York State. Environ Health Perspect2021; 129: 27003.
32.
MorkDBraunDZanobettiA. Time-lagged relationships between a decade of air pollution exposure and first hospitalization with Alzheimer's disease and related dementias. Environ Int2023; 171: 107694.
33.
WeuveJBennettEERankerL, et al.Exposure to air pollution in relation to risk of dementia and related outcomes: an updated systematic review of the epidemiological literature. Environ Health Perspect2021; 129: 96001.
34.
FuPGuoXCheungFMH, et al.The association between PM2. 5 exposure and neurological disorders: a systematic review and meta-analysis. Sci Total Environ2019; 655: 1240–1248.
35.
Tarasoff-ConwayJMCarareROOsorioRS, et al.Clearance systems in the brain—implications for Alzheimer disease. Nat Rev Neurol2015; 11: 457–470.
36.
CostaLGColeTBCoburnJ, et al.Neurotoxicity of traffic-related air pollution. Neurotoxicology2017; 59: 133–139.
37.
BabadjouniRMHodisDMRadwanskiR, et al.Clinical effects of air pollution on the central nervous system; A review. J Clin Neurosci2017; 43: 16–24.
38.
KilianJKitazawaM. The emerging risk of exposure to air pollution on cognitive decline and Alzheimer's disease – evidence from epidemiological and animal studies. Biomed J2018; 41: 141–162.
39.
WangJMaTMaD, et al.The impact of air pollution on neurodegenerative diseases. Ther Drug Monit2021; 43: 69–78.
40.
BishopKCKetchamJDKuminoffNV. Hazed and confused: the effect of air pollution on dementia. Rev Econ Stud2023; 90: 2188–2214.
41.
ZhuYShiYBartellSM, et al.Potential effects of long-term exposure to air pollution on dementia: a longitudinal analysis in American Indians aged 55 years and older. Int J Environ Res Public Health2024; 21: 128.
42.
SahuBMackosAFlodenA, et al.Particulate matter exposure exacerbates amyloid-β plaque deposition and gliosis in APP/PS1 mice. J Alzheimers Dis2021; 80: 761–774.
43.
CacciottoloMWangXDriscollI, et al.Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models. Transl Psychiatry2017; 7: e1022.
44.
Serrano-PozoADasSHymanB. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol2021; 20: 68–80.
45.
RajanKBBarnesLLWilsonRS, et al.Apolipoprotein E genotypes, age, race, and cognitive decline in a population sample. J Am Geriatr Soc2019; 67: 734–740.
46.
MielkeMMVemuriPRoccaWA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol2014; 6: 37–48.
47.
ZhengLSuBCuiFP, et al.Long-term exposure to PM2. 5 constituents, genetic susceptibility, and incident dementia: a prospective cohort study among 0.2 million older adults. Environ Sci Technol2025; 59: 4493–4504.
48.
YangLWanWYuC, et al.Associations between PM2. 5 exposure and Alzheimer’s disease prevalence among elderly in eastern China. Environ Health2022; 21: 119.
49.
YeMYangJLiJ, et al.Progress in mechanisms, pathways and cohort studies about the effects of PM2. 5 exposure on the central nervous system. Rev Environ Contam Toxicol2023; 261: 7.
50.
WangYShiLLeeM, et al.Long-term exposure to PM2. 5 and mortality among older adults in the southeastern US. Epidemiology2017; 28: 207–214.
51.
HuangXSteinmetzJMarshEK, et al.A systematic review with a burden of proof meta-analysis of health effects of long-term ambient fine particulate matter (PM2. 5) exposure on dementia. Nat Aging2025; 5: 897–908.
52.
ThiankhawKChattipakornNChattipakornSC. PM2. 5 exposure in association with AD-related neuropathology and cognitive outcomes. Environ Pollut2022; 292: 118320.
53.
ZhuXJiXShouY, et al.Recent advances in understanding the mechanisms of PM2. 5-mediated neurodegenerative diseases. Toxicol Lett2020; 329: 31–37.
54.
LiJDongYSongY, et al.Long-term effects of PM2. 5 components on blood pressure and hypertension in Chinese children and adolescents. Environ Int2022; 161: 107134.
55.
VodonosAAwadYASchwartzJ. The concentration-response between long-term PM2.5 exposure and mortality; A meta-regression approach. Environ Res2018; 166: 677–689.
56.
CoxLAT. Effects of exposure estimation errors on estimated exposure-response relations for PM2. 5. Environ Res2018; 164: 636–646.
57.
SchwartzJFengYCastroE, et al.Causal concentration-response modeling with continuous curves and exposure error correction: PM2. 5 and mortality in the Medicare cohort. Environ Health Perspect2025; 133: 67007.
58.
JbailyAZhouXLiuJ, et al.Air pollution exposure disparities across US population and income groups. Nature2022; 601: 228–233.
59.
CastilloMDKinneyPLSoutherlandV, et al.Estimating intra-urban inequities in PM2. 5-attributable health impacts: a case study for Washington, DC. Geohealth2021; 5: e2021GH000431.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
